AR

“Valuation still stretched after share price correction: SF’s share price has dropped c.20% after the announcement of a surprising Q1 ’21 net loss.” UBS noted this week in a note titled: “Is the recent correction a buying opportunity?”

Also, what about the M&A fillip? Gone.

The broker, which didn’t touch upon that side of things, however – reiterating its “Sell” recommendation but predicting more downside – is concerned about other matters as far as the purchase of Kerry is concerned, as “we see further downside ...

Subscription required for Premium stories

In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium
Premium subscriber
New Premium subscriber REGISTER

Comment on this article


You must be logged in to post a comment.